Nov 26, 2025 · Keytruda (pembrolizumab) is a PD-1 inhibitor used to treat multiple cancers, including melanoma, lung cancer, breast cancer, and more. Learn about how it works, FDA …

Aug 21, 2025 · Keytruda is a brand-name infusion approved to treat several types of cancer. Learn about side effects, warnings, dosage, and more.

Pembrolizumab works by binding to the protein PD-1 on the surface of certain immune cells called T cells, which keeps cancer cells from suppressing the immune system. This allows the …

KEYTRUDA is a prescription medicine used to treat a kind of cancer called triple-negative breast cancer (TNBC). KEYTRUDA may be used with chemotherapy medicines as treatment before …

Keytruda is the first immunotherapy called a checkpoint inhibitor approved for first‐line treatment of lung cancer. How Does Keytruda Work for NSCLC?

Keytruda (pembrolizumab) is a cancer chemotherapy drug that treats melanoma, lung cancer, and a host of other malignancies. It is often used in combination with other chemotherapy agents, …

1 day ago · KEYTRUDA, in combination with gemcitabine and cisplatin, is indicated for the treatment of patients with locally advanced unresectable or metastatic biliary tract cancer …

Mar 23, 2025 · What type of cancer does Keytruda treat particularly well? In clinical trials, the drug has demonstrated high efficacy in tumors with high tumor mutation burden (TMB), suggesting …

1 day ago · FDA approves pembrolizumab and enfortumab vedotin for neoadjuvant and adjuvant treatment of cisplatin-ineligible muscle-invasive bladder cancer.

Keytruda (generic name: pembrolizumab) is one of the most significant advancements in cancer treatment in the last decade. As a checkpoint inhibitor immunotherapy, Keytruda empowers …